See my $155,000+ Stock Portfolio: https://www.patreon.com/citizenoftheyear/posts

Pepsi and Coca-Cola stock have seen a big decline in recent months. Many have attributed the Dividend Kings stock price decline due to a new pharmaceutical product Ozempic potentially causing people to eat less. This could reduce obesity levels worldwide, but also cause less in sales for popular dividend stocks KO and PEP. Was this sell justified? I go over the facts! Follow me on YouTube: CitizenoftheYear!

Disclaimer:This is not financial advice and I am not a licensed financial advisor. Always do your own research before investing and work with a licensed financial advisor. These are my opinions for informational purposes only and not to be taken as investing advice. Some of the links on this page are affiliate links, meaning, at no additional cost to you, I may earn a commission if you click through and make a purchase and/or subscribe. Affiliate commissions help fund videos like this one.